aluates Reports

$ 0.0

Automative

Global Drug Phenotypic Screening Platform Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-36V15571

Global Drug Phenotypic Screening Platform Market Research Report 2023

BUY CHAPTERS

Global Drug Phenotypic Screening Platform Market Research Report 2025

Code: QYRE-Auto-36V15571

Report

May 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Creative-Biolabs

TargetMol

Mimetas

Evotec AG

ThermoScientific

Eurofins Discovery

Crown Bioscience

Pharmaron

HD Biosciences

Melior Discovery

Horizon Discovery

PerkinElmer Inc

Drug Phenotypic Screening Platform Market

The global market for Drug Phenotypic Screening Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Drug Phenotypic Screening Platform in Pharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Drug Phenotypic Screening Platform include Melior Discovery, Creative Biolabs, PerkinElmer, TargetMol, MIMETAS, Evotec, ThermoScientific, Eurofins Discovery, Horizon Discovery, Crown Bioscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Drug Phenotypic Screening Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Phenotypic Screening Platform.

The Drug Phenotypic Screening Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Phenotypic Screening Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Phenotypic Screening Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Phenotypic Screening Platform Market Report

Report Metric	Details
Report Name	Drug Phenotypic Screening Platform Market
Segment by Type	In Vivo Screening In Vitro Screening
Segment by Application	Pharmaceutical Company Research Institute Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Melior Discovery, Creative Biolabs, PerkinElmer, TargetMol, MIMETAS, Evotec, ThermoScientific, Eurofins Discovery, Horizon Discovery, Crown Bioscience, Pharmaron, HD Biosciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Phenotypic Screening Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Phenotypic Screening Platform Market report?

Ans: The main players in the Drug Phenotypic Screening Platform Market are Melior Discovery, Creative Biolabs, PerkinElmer, TargetMol, MIMETAS, Evotec, ThermoScientific, Eurofins Discovery, Horizon Discovery, Crown Bioscience, Pharmaron, HD Biosciences

What are the Application segmentation covered in the Drug Phenotypic Screening Platform Market report?

Ans: The Applications covered in the Drug Phenotypic Screening Platform Market report are Pharmaceutical Company, Research Institute, Others

What are the Type segmentation covered in the Drug Phenotypic Screening Platform Market report?

Ans: The Types covered in the Drug Phenotypic Screening Platform Market report are In Vivo Screening, In Vitro Screening

Recommended Reports

Drug Testing Markets

Diagnostics & Biomarkers

Pharma R&D Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 In Vivo Screening

1.2.3 In Vitro Screening

1.3 Market by Application

1.3.1 Global Drug Phenotypic Screening Platform Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Company

1.3.3 Research Institute

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Phenotypic Screening Platform Market Perspective (2020-2031)

2.2 Global Drug Phenotypic Screening Platform Growth Trends by Region

2.2.1 Global Drug Phenotypic Screening Platform Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drug Phenotypic Screening Platform Historic Market Size by Region (2020-2025)

2.2.3 Drug Phenotypic Screening Platform Forecasted Market Size by Region (2026-2031)

2.3 Drug Phenotypic Screening Platform Market Dynamics

2.3.1 Drug Phenotypic Screening Platform Industry Trends

2.3.2 Drug Phenotypic Screening Platform Market Drivers

2.3.3 Drug Phenotypic Screening Platform Market Challenges

2.3.4 Drug Phenotypic Screening Platform Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Phenotypic Screening Platform Players by Revenue

3.1.1 Global Top Drug Phenotypic Screening Platform Players by Revenue (2020-2025)

3.1.2 Global Drug Phenotypic Screening Platform Revenue Market Share by Players (2020-2025)

3.2 Global Drug Phenotypic Screening Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Phenotypic Screening Platform Revenue

3.4 Global Drug Phenotypic Screening Platform Market Concentration Ratio

3.4.1 Global Drug Phenotypic Screening Platform Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Phenotypic Screening Platform Revenue in 2024

3.5 Global Key Players of Drug Phenotypic Screening Platform Head office and Area Served

3.6 Global Key Players of Drug Phenotypic Screening Platform, Product and Application

3.7 Global Key Players of Drug Phenotypic Screening Platform, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Phenotypic Screening Platform Breakdown Data by Type

4.1 Global Drug Phenotypic Screening Platform Historic Market Size by Type (2020-2025)

4.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2026-2031)

5 Drug Phenotypic Screening Platform Breakdown Data by Application

5.1 Global Drug Phenotypic Screening Platform Historic Market Size by Application (2020-2025)

5.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drug Phenotypic Screening Platform Market Size (2020-2031)

6.2 North America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)

6.4 North America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Phenotypic Screening Platform Market Size (2020-2031)

7.2 Europe Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drug Phenotypic Screening Platform Market Size by Country (2020-2025)

7.4 Europe Drug Phenotypic Screening Platform Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Phenotypic Screening Platform Market Size (2020-2031)

8.2 Asia-Pacific Drug Phenotypic Screening Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2020-2025)

8.4 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Phenotypic Screening Platform Market Size (2020-2031)

9.2 Latin America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)

9.4 Latin America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Phenotypic Screening Platform Market Size (2020-2031)

10.2 Middle East & Africa Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2020-2025)

10.4 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Melior Discovery

11.1.1 Melior Discovery Company Details

11.1.2 Melior Discovery Business Overview

11.1.3 Melior Discovery Drug Phenotypic Screening Platform Introduction

11.1.4 Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.1.5 Melior Discovery Recent Development

11.2 Creative Biolabs

11.2.1 Creative Biolabs Company Details

11.2.2 Creative Biolabs Business Overview

11.2.3 Creative Biolabs Drug Phenotypic Screening Platform Introduction

11.2.4 Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.2.5 Creative Biolabs Recent Development

11.3 PerkinElmer

11.3.1 PerkinElmer Company Details

11.3.2 PerkinElmer Business Overview

11.3.3 PerkinElmer Drug Phenotypic Screening Platform Introduction

11.3.4 PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.3.5 PerkinElmer Recent Development

11.4 TargetMol

11.4.1 TargetMol Company Details

11.4.2 TargetMol Business Overview

11.4.3 TargetMol Drug Phenotypic Screening Platform Introduction

11.4.4 TargetMol Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.4.5 TargetMol Recent Development

11.5 MIMETAS

11.5.1 MIMETAS Company Details

11.5.2 MIMETAS Business Overview

11.5.3 MIMETAS Drug Phenotypic Screening Platform Introduction

11.5.4 MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.5.5 MIMETAS Recent Development

11.6 Evotec

11.6.1 Evotec Company Details

11.6.2 Evotec Business Overview

11.6.3 Evotec Drug Phenotypic Screening Platform Introduction

11.6.4 Evotec Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.6.5 Evotec Recent Development

11.7 ThermoScientific

11.7.1 ThermoScientific Company Details

11.7.2 ThermoScientific Business Overview

11.7.3 ThermoScientific Drug Phenotypic Screening Platform Introduction

11.7.4 ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.7.5 ThermoScientific Recent Development

11.8 Eurofins Discovery

11.8.1 Eurofins Discovery Company Details

11.8.2 Eurofins Discovery Business Overview

11.8.3 Eurofins Discovery Drug Phenotypic Screening Platform Introduction

11.8.4 Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.8.5 Eurofins Discovery Recent Development

11.9 Horizon Discovery

11.9.1 Horizon Discovery Company Details

11.9.2 Horizon Discovery Business Overview

11.9.3 Horizon Discovery Drug Phenotypic Screening Platform Introduction

11.9.4 Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.9.5 Horizon Discovery Recent Development

11.10 Crown Bioscience

11.10.1 Crown Bioscience Company Details

11.10.2 Crown Bioscience Business Overview

11.10.3 Crown Bioscience Drug Phenotypic Screening Platform Introduction

11.10.4 Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.10.5 Crown Bioscience Recent Development

11.11 Pharmaron

11.11.1 Pharmaron Company Details

11.11.2 Pharmaron Business Overview

11.11.3 Pharmaron Drug Phenotypic Screening Platform Introduction

11.11.4 Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.11.5 Pharmaron Recent Development

11.12 HD Biosciences

11.12.1 HD Biosciences Company Details

11.12.2 HD Biosciences Business Overview

11.12.3 HD Biosciences Drug Phenotypic Screening Platform Introduction

11.12.4 HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2020-2025)

11.12.5 HD Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Creative-Biolabs

TargetMol

Mimetas

Evotec AG

ThermoScientific

Eurofins Discovery

Crown Bioscience

Pharmaron

HD Biosciences

Melior Discovery

Horizon Discovery

PerkinElmer Inc

List of Tables

Table 1. Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of In Vivo Screening

Table 3. Key Players of In Vitro Screening

Table 4. Global Drug Phenotypic Screening Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Drug Phenotypic Screening Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Drug Phenotypic Screening Platform Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Drug Phenotypic Screening Platform Market Share by Region (2020-2025)

Table 8. Global Drug Phenotypic Screening Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Drug Phenotypic Screening Platform Market Share by Region (2026-2031)

Table 10. Drug Phenotypic Screening Platform Market Trends

Table 11. Drug Phenotypic Screening Platform Market Drivers

Table 12. Drug Phenotypic Screening Platform Market Challenges

Table 13. Drug Phenotypic Screening Platform Market Restraints

Table 14. Global Drug Phenotypic Screening Platform Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Drug Phenotypic Screening Platform Market Share by Players (2020-2025)

Table 16. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2024)

Table 17. Ranking of Global Top Drug Phenotypic Screening Platform Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Drug Phenotypic Screening Platform Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Drug Phenotypic Screening Platform, Headquarters and Area Served

Table 20. Global Key Players of Drug Phenotypic Screening Platform, Product and Application

Table 21. Global Key Players of Drug Phenotypic Screening Platform, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Drug Phenotypic Screening Platform Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2020-2025)

Table 25. Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2026-2031)

Table 27. Global Drug Phenotypic Screening Platform Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2020-2025)

Table 29. Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2026-2031)

Table 31. North America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Drug Phenotypic Screening Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)

Table 46. Melior Discovery Company Details

Table 47. Melior Discovery Business Overview

Table 48. Melior Discovery Drug Phenotypic Screening Platform Product

Table 49. Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 50. Melior Discovery Recent Development

Table 51. Creative Biolabs Company Details

Table 52. Creative Biolabs Business Overview

Table 53. Creative Biolabs Drug Phenotypic Screening Platform Product

Table 54. Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 55. Creative Biolabs Recent Development

Table 56. PerkinElmer Company Details

Table 57. PerkinElmer Business Overview

Table 58. PerkinElmer Drug Phenotypic Screening Platform Product

Table 59. PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 60. PerkinElmer Recent Development

Table 61. TargetMol Company Details

Table 62. TargetMol Business Overview

Table 63. TargetMol Drug Phenotypic Screening Platform Product

Table 64. TargetMol Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 65. TargetMol Recent Development

Table 66. MIMETAS Company Details

Table 67. MIMETAS Business Overview

Table 68. MIMETAS Drug Phenotypic Screening Platform Product

Table 69. MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 70. MIMETAS Recent Development

Table 71. Evotec Company Details

Table 72. Evotec Business Overview

Table 73. Evotec Drug Phenotypic Screening Platform Product

Table 74. Evotec Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 75. Evotec Recent Development

Table 76. ThermoScientific Company Details

Table 77. ThermoScientific Business Overview

Table 78. ThermoScientific Drug Phenotypic Screening Platform Product

Table 79. ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 80. ThermoScientific Recent Development

Table 81. Eurofins Discovery Company Details

Table 82. Eurofins Discovery Business Overview

Table 83. Eurofins Discovery Drug Phenotypic Screening Platform Product

Table 84. Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 85. Eurofins Discovery Recent Development

Table 86. Horizon Discovery Company Details

Table 87. Horizon Discovery Business Overview

Table 88. Horizon Discovery Drug Phenotypic Screening Platform Product

Table 89. Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 90. Horizon Discovery Recent Development

Table 91. Crown Bioscience Company Details

Table 92. Crown Bioscience Business Overview

Table 93. Crown Bioscience Drug Phenotypic Screening Platform Product

Table 94. Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 95. Crown Bioscience Recent Development

Table 96. Pharmaron Company Details

Table 97. Pharmaron Business Overview

Table 98. Pharmaron Drug Phenotypic Screening Platform Product

Table 99. Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 100. Pharmaron Recent Development

Table 101. HD Biosciences Company Details

Table 102. HD Biosciences Business Overview

Table 103. HD Biosciences Drug Phenotypic Screening Platform Product

Table 104. HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)

Table 105. HD Biosciences Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Drug Phenotypic Screening Platform Picture

Figure 2. Global Drug Phenotypic Screening Platform Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug Phenotypic Screening Platform Market Share by Type: 2024 VS 2031

Figure 4. In Vivo Screening Features

Figure 5. In Vitro Screening Features

Figure 6. Global Drug Phenotypic Screening Platform Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Drug Phenotypic Screening Platform Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Company Case Studies

Figure 9. Research Institute Case Studies

Figure 10. Others Case Studies

Figure 11. Drug Phenotypic Screening Platform Report Years Considered

Figure 12. Global Drug Phenotypic Screening Platform Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Drug Phenotypic Screening Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Drug Phenotypic Screening Platform Market Share by Region: 2024 VS 2031

Figure 15. Global Drug Phenotypic Screening Platform Market Share by Players in 2024

Figure 16. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Drug Phenotypic Screening Platform Revenue in 2024

Figure 18. North America Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Drug Phenotypic Screening Platform Market Share by Country (2020-2031)

Figure 20. United States Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Drug Phenotypic Screening Platform Market Share by Country (2020-2031)

Figure 24. Germany Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Drug Phenotypic Screening Platform Market Share by Region (2020-2031)

Figure 32. China Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Drug Phenotypic Screening Platform Market Share by Country (2020-2031)

Figure 40. Mexico Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Drug Phenotypic Screening Platform Market Share by Country (2020-2031)

Figure 44. Turkey Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Melior Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 48. Creative Biolabs Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 49. PerkinElmer Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 50. TargetMol Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 51. MIMETAS Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 52. Evotec Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 53. ThermoScientific Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 54. Eurofins Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 55. Horizon Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 56. Crown Bioscience Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 57. Pharmaron Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 58. HD Biosciences Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Phenotypic Drug Discovery Market

Global Application Platform Market Research Report 2025

Global Computer assisted Drug Design Platform Market Research Report 2024

Global Marketing Platform Market Research Report 2024

Global Cloud Based Drug Discovery Platforms Market Research Report 2024

Global Drug Screening System Market Research Report 2025

Global Software Development Platform Market Research Report 2024

Global Marketing Platform Market Research Report 2025

Drug Discovery Screening Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Developing Platforms by Artificial Intelligence AI Market Research Report 2024

Global Cosmetics Procurement Platform Market Research Report 2025

Global Antibody Discovery Platforms Market Research Report 2025

Drug Screening Laboratory Service Market

Global Platform Scales Market Research Report 2024

Global Sales Platform Market Research Report 2025

Global Psychological Testing Platform Market Research Report 2024

Global Health Management Platform Market Research Report 2025

AI Drug Discovery Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Portable Platform Market Research Report 2024

AI Drug Development Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions